Mapping of antigenic determinants on a SAT2 foot-and-mouth disease virus using chicken single-chain antibody fragments

Virus Research

Volumn 167, Issue 2, 2012, Pages 370-379

  Opperman, Pamela A ^a,b   Maree, Francois F ^a,b   Van Wyngaardt, Wouter ^a   Vosloo, Wilna ^b,c   Theron, Jacques ^b  

^a ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c Australian Animal Health Laboratory   (Australia)

Author keywords

Antigenic site; Epitope; Foot and mouth disease; Phage display; SAT2; Single chain variable fragment

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN VP1; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; DNA SEQUENCE; EPITOPE MAPPING; FOOT AND MOUTH DISEASE VIRUS; IMMUNOGENICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PRIORITY JOURNAL; SEROTYPE; VIRUS IMMUNITY; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CHICKENS; CRICETINAE; EPITOPE MAPPING; EPITOPES; FOOT-AND-MOUTH DISEASE VIRUS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; SINGLE-CHAIN ANTIBODIES;

FOOT-AND-MOUTH DISEASE VIRUS;

EID: 84863867876     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.05.026     Document Type: Article

References (80)

1. Acharya R., Fry E., Stuart D., Fox G., Rowlands D., Brown F. The three-dimensional structure of foot-and-mouth disease virus at 2.9Å resolution. Nature 1989, 337:709-716.
2. Andris-Widhopf J., Rader C., Steinberger P., Fuller R., Barbas C.F. Methods for the generation of chicken monoclonal antibody fragments by phage display. Journal of Immunological Methods 2000, 242:159-181.
3. Barnett P.V., Ouldridge E.J., Rowlands D.J., Brown F., Parry N. Neutralizing epitopes on type O foot-and-mouth-disease virus. I. Identification and characterization of three functionally independent, conformational sites. Journal of General Virology 1989, 70:1483-1491.
4. Bastos A.D.S. Detection and characterization of the foot-and-mouth disease virus in sub-Saharan Africa. Onderstepoort Journal of Veterinary Research 1998, 65:37-47.
5. Bastos A.D.S., Anderson E.C., Bengis R.G., Keet D.F., Winterbach H.K., Thomson G.R. Molecular epidemiology of SAT3-type foot-and-mouth disease. Virus Genes 2003, 27:283-290.
6. Bastos A.D.S., Boshoff C.I., Keet D.F., Bengis R.G., Thomson G.R. Natural transmission of foot-and-mouth disease virus between African buffalo (Syncerus caffer) and impala (Aepyceros melampus) in the Kruger National Park, South Africa. Epidemiology and Infection 2000, 124:591-598.
7. Bastos A.D.S., Haydon D., Forsberg R., Knowels N., Anderson E., Bengis R., Nel L.H., Thomson G. Genetic heterogeneity of SAT-1 type foot-and-mouth disease viruses in southern Africa. Archives of Virology 2001, 146:1537-1551.
8. Bastos A.D.S., Haydon D.T., Sangaré O., Boshoff C.I., Edrich J.L., Thomson G.R. The implication of viral diversity within the SAT 2 serotype for control of foot-and-mouth disease in sub-Saharan Africa. Journal of General Virology 2003, 84:1595-1606.
9. 12 foot-and-mouth disease virus. Journal of Virology 1989, 63:2143-2151.
10. Bich C., Scott M., Panagiotidis A., Wenzel R.J., Nazabal A., Zenobi R. Characterization of antibody-antigen interactions: comparison between surface plasmon resonance measurements and high-mass matrix-assisted laser desorption/ionization mass spectrometry. Analytical Biochemistry 2008, 375:35-45.
11. Blignaut B., Visser N., Theron J., Rieder E., Maree F.F. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune response in pigs. Journal of General Virology 2011, 92:849-859.
12. Bolwell C., Clarke B.E., Parry N.R., Ouldridge E.J., Brown F., Rowlands D.J. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies. Journal of General Virology 1989, 70:59-68.
13. Brichta J., Hnilova M., Viskovic T. Generation of hapten-specific recombinant antibodies: antibody phage display technology: a review. Veterinarni Medicina 2005, 50:231-252.
14. Brooksby J.B. Epizootiology of foot-and-mouth disease virus in developing countries. World Animal Review 1972, 3:10-13.
15. Burton D.R., Stanfield R.L., Wilson I.A. Antibody vs. HIV in a clash of evolutionary titans. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:14943-14948.
16. Carmen S., Jermutus L. Concepts on phage display. Briefings in Functional Genomics & Proteomics 2002, 1:189-203.
17. Clackson T., Hoogenboom H.R., Griffiths A.D., Winter G. Making antibody fragments using phage display libraries. Nature 1991, 352:624-628.
18. Crowther J.R., Farias S., Carpenter W.C., Samuel A.R. Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. Journal of General Virology 1993, 74:1533-1547.
19. Crowther J.R., Rowe C.A., Butcher R. Characterization of monoclonal antibodies against a type SAT2 foot-and-mouth disease virus. Epidemiology and Infection 1993, 111:391-406.
20. Curry S., Fry E., Blakemore W., Abu-Ghazaleh R., Jackson T., King A., Lea S., Newman J., Rowlands D., Stuart D. Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Structure 1996, 4:135-145.
21. Davidson F.L., Crowther J.R., Nqindi J., Knowles N.J., Thevasagayam S.J., Van Vuuren C.J. Antigenic analysis of SAT2 serotype foot-and-mouth disease virus isolates from Zimbabwe using monoclonal antibodies. Epidemiology and Infection 1995, 115:193-205.
22. Dawe P.S., Flanagan F.O., Madekurozwa R.L., Sorensen K.J., Anderson E.C., Foggin C.M., Ferris N.P., Knowles N.J. Natural transmission of foot-and-mouth disease virus from African buffalo (Syncerus caffer) to cattle in a wildlife area of Zimbabwe. Veterinary Record 1994, 134:230-232.
23. Domingo E., Holland J.J. RNA virus mutations and fitness for survival. Annual Review of Microbiology 1997, 51:151-178.
24. Domingo E., Verdaguer N., Ochoa W.F., Ruiz-Jarabo C.M., Sevilla N., Barnowski E., Mateu M.G., Fita I. Biochemical and structural studies with neutralizing antibodies raised against foot-and-mouth disease virus. Virus Research 1999, 62:169-175.
25. Esterhuysen J.J., Thomson G.R., Ashford W.A., Lentz D.W., Gainaru M.D., Sayer A.J., Meredith C.D., Janse van Rensburg D., Pini A. The suitability of a rolled BHK21 monolayer system for the production of vaccines against the SAT types of foot-and-mouth disease virus. I. Adaptation of virus isolates to the system, immunogen yields achieved and assessment of subtype cross reactivity. Onderstepoort Journal of Veterinary Research 1988, 55:77-84.
26. Fehrsen J., Van Wyngaardt W., Mashau C., Potgieter A.C., Chaudhary V.K., Gupta A., Jordaan F.A., Du Plessis D.H. Serogroup-reactive and type specific detection of bluetongue virus antibodies using chicken scFvs in inhibition ELISAs. Journal of Virological Methods 2005, 129:31-39.
27. Feigelstock D., Mateu M.G., Piccone M.E., De Simone F., Brocchi E., Domingo E., Palma E.L. Extensive antigenic diversification of foot-and-mouth disease virus by amino acid substitutions outside the major antigenic site. Journal of General Virology 1992, 73:3307-3311.
28. Feigelstock D.A., Mateu M.G., Valero M.L., Andreu D., Domingo E., Palma L. Emerging foot-and-mouth disease virus variants with antigentically critical amino acid substitutions predicted by model studies using reference viruses. Vaccine 1996, 14:97-102.
29. Ferris N.P., Donaldson E.C. The World Reference Laboratory for foot-and-mouth disease: a review of thirty-three years of activity (1958-1991). Revue Scientifique et Technique 1992, 11:657-684.
30. Fowler V.I., Knowles N.J., Paton D.J., Barnett P.V. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion. Vaccine 2010, 28:3428-3434.
31. Fowler V.L., Paton D.J., Rieder E., Barnett P.V. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy a potential marker vaccines in cattle. Vaccine 2008, 26:1982-1989.
32. Fox G., Parry N.R., Barnett P.V., McGinn B., Rowlands D.J., Brown F. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). Journal of General Virology 1989, 70:625-637.
33. Gram H., Marconi L.A., Babas C.F., Collet T.A., Lerner R.A., Kang A.S. In vitro selection and affinity maturation of antibodies from a naïve combinatorial immunoglobulin library. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:3576-3580.
34. Grazioli S., Moretti M., Barbieri I., Crosatti M., Brocchi E. Use of monoclonal antibodies to identify and map new antigenic determinants involved in neutralization on FMD viruses type SAT 1 and SAT 2. European Commission for the Control of Foot-and-Mouth Disease: International Control of Foot-and-Mouth Disease: Tools, Trends and Perspectives 2006.
35. Guthridge J.M., Young K., Gipson M.G., Sarrias M.R., Szakonyi G., Chen X.S., Malaspina A., Donoghue E., James J.A., Lambris J.D., Moir S.A., Perkins S.J., Holers V.M. Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface. Journal of Immunology 2001, 167:5758-5766.
36. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98NT. Nucleic Acids Symposium Series 1999, 41:95-98.
37. Holland J., Spindler K., Horodyski F., Grabau E., Nichol S., Vandepol S. Rapid evolution of RNA genomes. Science 1982, 215:1577-1585.
38. Irving M.B., Pan O., Scott J.K. Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics. Current Opinion in Chemical Biology 2001, 5:314-324.
39. Joseph T., Lyaku J., Fredrickson R.A., Cepica A., Kibenge F.S.B. Use of epitope mapping to identify a PCR template for protein amplification and detection by enzyme-linked immunosorbent assay of bovine herpesvirus type 1 glycoprotein D. Journal of Clinical Microbiology 2002, 40:4045-4050.
40. Katpally U., Fu T.M., Freed D.C., Casimiro D.R., Smith T.J. Antibodies to the buried N terminus of Rhinovirus VP4 exhibit cross-serotypic neutralization. Journal of Virology 2009, 83:7040-7048.
41. King A.M.Q., Brown F., Christian P., Hovi T., Hyypia T., Knowles N.J., Lemon S.M., Minor P.D., Palmenberg A.C., Skern T., Stanway G. Picornaviridae. Virus Taxonomy: Seventh Report of the International Committee for the Taxonomy of Viruses 2000, 657-673. Academic Press, New York, San Diego, California. M.H.V. Van Regenmortel, C.M. Fauquet, D.H.L. Bishop, C.H. Calisher, E.B. Carsten, M.K. Estes, S.M. Lemon, J. Maniloff, M.A. Mayo, D.J. McGeoch, C.R. Pringle, R.B. Wickner (Eds.).
42. Kitson J.D.A., McCahon D., Belsham G.J. Sequence analysis of monoclonal antibody resistant mutants of type O foot-and-mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 1990, 179:26-34.
43. Kleymann G., Iwata S., Wiesmüller K.H., Ludwig B., Haase W., Michel H. Immunoelectron microscopy and epitope mapping with monoclonal antibodies suggest the existence of an additional N-terminal transmembrane helix in the cytochrome b subunit of bacterial ubiquionl: cytochrome-c oxidoreductases. European Journal of Biochemistry 1995, 230:359-363.
44. Knipe T., Rieder E., Baxt B., Ward G., Mason P.W. Characterization of synthetic foot-and-mouth disease virus provirions separates acid-mediated disassembly from infectivity. Journal of Virology 1997, 71:2851-2856.
45. Lea S., Hernandez J., Blakemore W., Brocchi E., Curry S., Domingo E., Fry E., Abu-Ghazaleh R., King A., Newman J., Stuart D., Mateu M.G. The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 1994, 2:123-139.
46. Li Q., Yafal A.G., Lee Y.M.H., Hogel J., Chow M. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperatures. Journal of Virology 1994, 68:3965-3970.
47. Logan D., Abu-Ghazaleh R., Blakemore W., Curry S., Jackson T., King A., Lea S., Lewis R., Newman J., Parry N., Rowlands D., Stuart D., Fry E. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 1993, 362:566-568.
48. Maree F.F., Blignaut B., Esterhuysen J.J., De Beer T.A.P., Theron J., O'Neil H.G., Rieder E. Predicting antigenic sites on the foot-and-mouth disease virus capsid of the South African Territories (SAT) types using virus neutralization data. Journal of General Virology 2011, 92:2297-2309.
49. Mason P.W., Rieder E., Baxt B. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:1932-1936.
50. Mateo R., Mateu M.G. Deterministic, compensatory mutational events in the capsid of foot-and-mouth disease virus in response to the introduction of mutations found in viruses from persistent infections. Journal of Virology 2007, 81:1879-1887.
51. Mateu M.G., Camarero J.A., Giralt E., Andreu D., Domingo E. Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 1995, 206:298-306.
52. Mateu M.G., Martinez M.A., Capucci L., Andreu D., Giralt E., Sobrino F., Brocchi E., Domingo E. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. Journal of General Virology 1990, 71:629-637.
53. Morrel D.J., Mellor E.J.C., Rowlands D.J., Brown F. Surface structure and RNA-protein interaction of foot-and-mouth disease virus. Journal of General Virology 1987, 68:1649-1658.
54. Parry R., Barnett P.V., Ouldridge E.J., Rowlands D.J., Brown F. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. Journal of General Virology 1989, 70:1493-1503.
55. Pfaff E., Thiel H.-J., Beck E., Strohmaier K., Schaller H. Analysis of neutralizing epitopes on foot-and-mouth disease virus. Journal of Virology 1988, 62:2033-2040.
56. Purcell A.W., McCluskey J., Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nature Reviews Drug Discovery 2007, 6:404-414.
57. Rakabe, M., 2008. Selection of chicken single-chain antibody fragments directed against recombinant VP7 of bluetongue virus. M. Sc. Thesis. University of Pretoria, South Africa.
58. Reeve R., Blignaut B., Esterhuysen J.J., Opperman P., Matthews L., Fry E., De Beer T.A.P., Theron J., Rieder E., Vosloo W., O'Neill H.G., Haydon D.T., Maree F.F. Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus. PLoS Computational Biology 2010, 6:1-13.
59. Rieder E., Bunch T., Brown F., Mason P.W. Genetically engineered foot-and-mouth disease viruses with poly (C) tracts of two nucleotides are virulent in mice. Journal of Virology 1993, 67:5139-5145.
60. Roivainen M., Piirainen L., Hovi T. Persistence and class-specificity of neutralizing antibody response induced by trypsin-cleaved type 3 poliovirus in mice. Vaccine 1993, 11:713-717.
61. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology 1993, 234:779-815.
62. Sanyal A., Venkatamanan R., Pattnaik B. Antigenic features of foot-and-mouth disease virus serotype Asia 1 as revealed by monoclonal antibodies and neutralization-escape mutants. Virus Research 1997, 50:107-117.
63. Sette A., Fike J. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Current Opinion in Immunology 2003, 15:461-470.
64. Shao J.J., Wong C.K., Lin T., Lee S.K., Cong G.Z., Sin F.W.Y., Du J.Z., Gao S.D., Liu X.T., Cai X.P., Xie Y., Chang H.Y., Liu J.X. Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine. Clinical and Vaccine Immunology 2011, 18:143-149.
65. Sixholo, J., 2008. Engineering recombinant chicken antibodies for improved characteristics. M. Sc Thesis. University of Pretoria, South Africa.
66. Smith G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985, 228:1315-1317.
67. Tamura K., Dudley J., Nei M., Kumar S. MEGA 4: Molecular Evolutionary Genetics Analysis software version 4.0. Molecular Biology and Evolution 2007, 24:1596-1599.
68. Thomas A.A.M., Woortmeijer R.J., Puijk W., Barteing S.J. Antigenic sites on foot-and-mouth disease virus type A10. Journal of Virology 1988, 62:2782-2789.
69. Thomson G.R., Bastos A.D.S. Foot-and-mouth disease. Infectious Diseases of Livestock 2004, 1324-1365. Oxford University Press, Cape Town, South Africa. J.A.W. Coetzer, R.C. Tustin (Eds.).
70. Van Rensburg H., Haydon D., Joubert F., Bastos A., Heath L., Nel L. Genetic heterogeneity in the foot-and-mouth disease virus Leader and 3C proteinases. Gene 2002, 289:19-29.
71. Van Rensburg H.G., Henry T.M., Mason P.W. Studies of genetically defined chimeras of a European type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus. Journal of General Virology 2004, 85:61-68.
72. Van Wyngaardt W., Malatji T., Mashau C., Fehrsen J., Jordaan F., Miltiadou D., Du Plessis D.H. A large semi-synthetic single-chain Fv phage display library based on chicken immunoglobulin genes. BMC Biotechnology 2004, 4:6.
73. Verdaguer N., Fita I., Domingo E., Mateu M. Efficient neutralization of foot-and-mouth disease by monovalent antibody binding. Journal of Virology 1997, 71:9813-9816.
74. Vosloo W., Bastos A.D.S., Kirkbride E., Esterhuysen J.J., Van Rensburg D.J., Bengis R.G., Keet D.W., Thomson G.R. Persistent infection of African buffalo (Syncerus caffer) with SAT-type foot-and-mouth disease viruses: rate of fixation of mutations, antigenic change and interspecies transmission. Journal of General Virology 1996, 77:1457-1467.
75. Vosloo W., Bastos A.D.S., Sangare O., Hargreaves S.K., Thomson G.R. Review of the status and control of foot-and-mouth disease in sub-Saharan Africa. Revue Scientifique et Technique de l Office International des Epizooties 2002, 21:437-449.
76. Vosloo W., Thomson G.R. Natural habitats in which foot-and-mouth disease viruses are maintained. Foot-and-Mouth Disease: Current Perspectives 2004, 384-410. Horizon Bioscience, Norfolk, United Kingdom. E. Domingo, F. Sobrino (Eds.).
77. Walker B.D., Burton D.R. Towards an AIDS vaccine. Science 2008, 320:760-764.
78. H fusions directed against HSP65 Mycobacterium bovis. Biological 2010, 38:407-414.
79. Winter G., Griffiths A., Hawkins R.E., Hoogenboom H.R. Making antibodies by phage display technology. Annual Review of Immunology 1994, 12:433-455.
80. Xie Q.C., McCahon D., Crowther J.R., Belsham G.J., McCullough K.C. Neutralisation of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. Journal of General Virology 1987, 68:1637-1647.